Yayıncı "Springer Nature" Scopus İndeksli Yayınlar Koleksiyonu için listeleme
Toplam kayıt 5, listelenen: 1-5
-
Correction: Donor lymphocyte infusions after haploidentical stem cell transplantation with PTCY: A study on behalf of the EBMT cellular therapy & immunobiology working party (Bone Marrow Transplantation, (2023), 58, 1, (54-60), 10.1038/s41409-022-01839-8)
(Springer Nature, 2023)The color coding for our three subsets of patients were not identical in Figure 1 and Figure 2. While the "therapeutic" subset appears in green in both figures, the "pre-emptive" group appears in blue in Figure 1 and in ... -
Correction: The therapeutic effect of ALT-711 on erectile function in rats treated with high-level AGEs (advanced glycation end products) containing diet (International Journal of Impotence Research, (2022), 34, 2, (222-228), 10.1038/s41443-021-00417-8)
(Springer Nature, 2022)In this article, the author name A. Ender Caylan was incorrectly written as E. Ceylan. © The Author(s), under exclusive licence to Springer Nature Limited part of Springer Nature 2022. -
Sequential vs myeloablative vs reduced intensity conditioning for patients with myelodysplastic syndromes with an excess of blasts at time of allogeneic haematopoietic cell transplantation: a retrospective study by the chronic malignancies working party of the EBMT
(Springer Nature, 2023)The optimal conditioning for patients with higher risk MDS receiving potentially curative allogeneic haematopoietic stem cell transplant(allo-HCT) remains to be defined. This is particularly the case for patients with ... -
The therapeutic effect of ALT-711 on erectile function in rats treated with high-level AGEs (advanced glycation end products) containing diet
(Springer Nature, 2021)To investigate, if advanced glycation end products (AGEs) are involved in erectile dysfunction (ED) and also ALT-711, a cross-link breaker of AGEs, has the therapeutic potential against the development of ED in rats treated ... -
The therapeutic effect of ALT-711 on erectile function in rats treated with high-level AGEs (advanced glycation end products) containing diet
(Springer Nature, 2022)To investigate, if advanced glycation end products (AGEs) are involved in erectile dysfunction (ED) and also ALT-711, a cross-link breaker of AGEs, has the therapeutic potential against the development of ED in rats treated ...